Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Canaccord Genuity adjusted its stance on Evolution Mining Ltd. (EVN:AU) (OTC: CAHPF), downgrading the company's stock rating from Buy to Hold while maintaining a price target of AUD6.15. Currently ...

Elastic (NYSE:ESTC – Free Report) had its price objective lifted by Canaccord Genuity Group from $130.00 to $135.00 in a ...

Fintel reports that on February 28, 2025, Canaccord Genuity downgraded their outlook for ICF International (NasdaqGS:ICFI) ...

Canaccord Genuity raised its price target on Snowflake (NYSE:SNOW) by $30 to $220, as company is set to report fourth-quarter earnings on Wednesday. Stabilizing growth and AI-driven expansion are key ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to Canaccord Genuity Group Inc. Chief Executive Officer Daniel Daviau ...

Analysts at Canaccord Genuity lowered their target price on discount retailer B&M from 545.0p to 495.0p on Tuesday following ...

Analysts at Canaccord Genuity reiterated their 135.0p target price on airside solutions developer Aurrigo International on ...